Related Experiment Video
Updated: Jan 20, 2026
The Apoplast and Symplast Transport in Plants
Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment
Camila Downey1, Guillermo Pino2, María José Zambrano1
1Department of Dermatology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Insights
A rare symplastic hemangioma developed over a child's infantile hemangioma during propranolol treatment. This case emphasizes considering symplastic hemangioma in diagnosing new vascular lesions in children with existing ones.
Area of Science:
- Dermatology
- Pediatrics
- Pathology
Background:
- Infantile hemangiomas (IHs) are common benign vascular tumors in infants.
- Propranolol is a first-line treatment for IHs, often leading to significant involution.
- Complications or unusual developments during IH treatment require careful monitoring and diagnosis.
Abstract:
We describe a case of a 6-month-old female patient with a segmental, superficial, infantile hemangioma (IH) on the forehead being treated with propranolol 2 mg/kg/d for 5 months, who developed a symplastic hemangioma (SH) over the preexisting lesion, highlighting the need to consider SH in the differential diagnosis of vascular lesions arising over preexisting vascular anomalies in children.
Related Concept Videos
The Apoplast and Symplast
03:49Application of Microwave Ablation in Laparoscopic Partial Splenectomy
05:30Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

